nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP11A1—type 2 diabetes mellitus	0.221	0.621	CbGaD
Terbinafine—CYP1A2—type 2 diabetes mellitus	0.0811	0.228	CbGaD
Terbinafine—CYP3A4—type 2 diabetes mellitus	0.0537	0.151	CbGaD
Terbinafine—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0213	0.0492	CbGbCtD
Terbinafine—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0213	0.0492	CbGbCtD
Terbinafine—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0196	0.0454	CbGbCtD
Terbinafine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.017	0.0393	CbGbCtD
Terbinafine—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0161	0.0373	CbGbCtD
Terbinafine—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0154	0.0357	CbGbCtD
Terbinafine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0136	0.0314	CbGbCtD
Terbinafine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0123	0.0284	CbGbCtD
Terbinafine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0121	0.028	CbGbCtD
Terbinafine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0118	0.0274	CbGbCtD
Terbinafine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0113	0.0262	CbGbCtD
Terbinafine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0109	0.0253	CbGbCtD
Terbinafine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0108	0.025	CbGbCtD
Terbinafine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0103	0.0238	CbGbCtD
Terbinafine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0103	0.0238	CbGbCtD
Terbinafine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0101	0.0233	CbGbCtD
Terbinafine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0095	0.022	CbGbCtD
Terbinafine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00917	0.0212	CbGbCtD
Terbinafine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00891	0.0206	CbGbCtD
Terbinafine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00876	0.0203	CbGbCtD
Terbinafine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00856	0.0198	CbGbCtD
Terbinafine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00856	0.0198	CbGbCtD
Terbinafine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0079	0.0183	CbGbCtD
Terbinafine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00782	0.0181	CbGbCtD
Terbinafine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00772	0.0179	CbGbCtD
Terbinafine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00763	0.0176	CbGbCtD
Terbinafine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00722	0.0167	CbGbCtD
Terbinafine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00698	0.0161	CbGbCtD
Terbinafine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0069	0.016	CbGbCtD
Terbinafine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00688	0.0159	CbGbCtD
Terbinafine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00653	0.0151	CbGbCtD
Terbinafine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00649	0.015	CbGbCtD
Terbinafine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00629	0.0146	CbGbCtD
Terbinafine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00622	0.0144	CbGbCtD
Terbinafine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00593	0.0137	CbGbCtD
Terbinafine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00574	0.0133	CbGbCtD
Terbinafine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00569	0.0132	CbGbCtD
Terbinafine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0055	0.0127	CbGbCtD
Terbinafine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00527	0.0122	CbGbCtD
Terbinafine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00498	0.0115	CbGbCtD
Terbinafine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00482	0.0111	CbGbCtD
Terbinafine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00445	0.0103	CbGbCtD
Terbinafine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00438	0.0101	CbGbCtD
Terbinafine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00401	0.00927	CbGbCtD
Terbinafine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00377	0.00872	CbGbCtD
Terbinafine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00362	0.00836	CbGbCtD
Terbinafine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00362	0.00836	CbGbCtD
Terbinafine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00342	0.00791	CbGbCtD
Terbinafine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00255	0.00589	CbGbCtD
Terbinafine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00233	0.00539	CbGbCtD
Terbinafine—Naphazoline—ADRA2A—type 2 diabetes mellitus	0.000554	0.442	CrCbGaD
Terbinafine—Propranolol—ADRB3—type 2 diabetes mellitus	0.000459	0.366	CrCbGaD
Terbinafine—SQLE—islet of Langerhans—type 2 diabetes mellitus	0.000203	0.135	CbGeAlD
Terbinafine—SQLE—retina—type 2 diabetes mellitus	0.000173	0.115	CbGeAlD
Terbinafine—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000144	0.115	CrCbGaD
Terbinafine—SQLE—pancreas—type 2 diabetes mellitus	0.000142	0.0949	CbGeAlD
Terbinafine—SQLE—adipose tissue—type 2 diabetes mellitus	0.000129	0.0861	CbGeAlD
Terbinafine—PTGS1—artery—type 2 diabetes mellitus	0.000104	0.0694	CbGeAlD
Terbinafine—Propranolol—CYP3A4—type 2 diabetes mellitus	9.56e-05	0.0763	CrCbGaD
Terbinafine—SQLE—liver—type 2 diabetes mellitus	9.06e-05	0.0604	CbGeAlD
Terbinafine—PTGS1—endothelium—type 2 diabetes mellitus	8.81e-05	0.0587	CbGeAlD
Terbinafine—CYP11A1—adipose tissue—type 2 diabetes mellitus	8.47e-05	0.0564	CbGeAlD
Terbinafine—Urticaria—Glyburide—type 2 diabetes mellitus	6.87e-05	0.000497	CcSEcCtD
Terbinafine—Angioedema—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000497	CcSEcCtD
Terbinafine—Skin disorder—Orlistat—type 2 diabetes mellitus	6.85e-05	0.000496	CcSEcCtD
Terbinafine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	6.84e-05	0.000496	CcSEcCtD
Terbinafine—Abdominal pain—Glyburide—type 2 diabetes mellitus	6.83e-05	0.000495	CcSEcCtD
Terbinafine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	6.83e-05	0.000495	CcSEcCtD
Terbinafine—Anorexia—Valsartan—type 2 diabetes mellitus	6.8e-05	0.000492	CcSEcCtD
Terbinafine—Muscle spasms—Losartan—type 2 diabetes mellitus	6.8e-05	0.000492	CcSEcCtD
Terbinafine—Asthenia—Bromocriptine—type 2 diabetes mellitus	6.79e-05	0.000491	CcSEcCtD
Terbinafine—Chest pain—Metformin—type 2 diabetes mellitus	6.78e-05	0.000491	CcSEcCtD
Terbinafine—Myalgia—Metformin—type 2 diabetes mellitus	6.78e-05	0.000491	CcSEcCtD
Terbinafine—Malaise—Irbesartan—type 2 diabetes mellitus	6.77e-05	0.000491	CcSEcCtD
Terbinafine—Vertigo—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000489	CcSEcCtD
Terbinafine—Headache—Pioglitazone—type 2 diabetes mellitus	6.74e-05	0.000488	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	6.73e-05	0.000487	CcSEcCtD
Terbinafine—Visual impairment—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000486	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	6.7e-05	0.000485	CcSEcCtD
Terbinafine—Discomfort—Metformin—type 2 diabetes mellitus	6.69e-05	0.000485	CcSEcCtD
Terbinafine—Fatigue—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.000485	CcSEcCtD
Terbinafine—Nausea—Glipizide—type 2 diabetes mellitus	6.67e-05	0.000483	CcSEcCtD
Terbinafine—Vomiting—Glimepiride—type 2 diabetes mellitus	6.67e-05	0.000483	CcSEcCtD
Terbinafine—Vision blurred—Losartan—type 2 diabetes mellitus	6.66e-05	0.000482	CcSEcCtD
Terbinafine—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.64e-05	0.000481	CcSEcCtD
Terbinafine—Pain—Gliclazide—type 2 diabetes mellitus	6.64e-05	0.000481	CcSEcCtD
Terbinafine—Rash—Glimepiride—type 2 diabetes mellitus	6.61e-05	0.000479	CcSEcCtD
Terbinafine—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.6e-05	0.000478	CcSEcCtD
Terbinafine—Rash—Sitagliptin—type 2 diabetes mellitus	6.59e-05	0.000477	CcSEcCtD
Terbinafine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.58e-05	0.000477	CcSEcCtD
Terbinafine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	6.58e-05	0.000477	CcSEcCtD
Terbinafine—Headache—Glimepiride—type 2 diabetes mellitus	6.57e-05	0.000476	CcSEcCtD
Terbinafine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.56e-05	0.000475	CcSEcCtD
Terbinafine—Cough—Irbesartan—type 2 diabetes mellitus	6.55e-05	0.000475	CcSEcCtD
Terbinafine—Headache—Sitagliptin—type 2 diabetes mellitus	6.55e-05	0.000474	CcSEcCtD
Terbinafine—Anaemia—Losartan—type 2 diabetes mellitus	6.53e-05	0.000473	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.5e-05	0.000471	CcSEcCtD
Terbinafine—Tinnitus—Ramipril—type 2 diabetes mellitus	6.49e-05	0.00047	CcSEcCtD
Terbinafine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.47e-05	0.000469	CcSEcCtD
Terbinafine—Angioedema—Losartan—type 2 diabetes mellitus	6.46e-05	0.000468	CcSEcCtD
Terbinafine—Infection—Metformin—type 2 diabetes mellitus	6.45e-05	0.000467	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.42e-05	0.000465	CcSEcCtD
Terbinafine—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.41e-05	0.000464	CcSEcCtD
Terbinafine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.4e-05	0.000463	CcSEcCtD
Terbinafine—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000463	CcSEcCtD
Terbinafine—Myalgia—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000463	CcSEcCtD
Terbinafine—Chest pain—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000463	CcSEcCtD
Terbinafine—Malaise—Losartan—type 2 diabetes mellitus	6.37e-05	0.000462	CcSEcCtD
Terbinafine—Anxiety—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000462	CcSEcCtD
Terbinafine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.37e-05	0.000461	CcSEcCtD
Terbinafine—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.37e-05	0.000461	CcSEcCtD
Terbinafine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.36e-05	0.000461	CcSEcCtD
Terbinafine—Vertigo—Losartan—type 2 diabetes mellitus	6.35e-05	0.00046	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.00046	CcSEcCtD
Terbinafine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.35e-05	0.00046	CcSEcCtD
Terbinafine—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.33e-05	0.000458	CcSEcCtD
Terbinafine—Discomfort—Irbesartan—type 2 diabetes mellitus	6.32e-05	0.000458	CcSEcCtD
Terbinafine—Skin disorder—Metformin—type 2 diabetes mellitus	6.31e-05	0.000457	CcSEcCtD
Terbinafine—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000455	CcSEcCtD
Terbinafine—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.28e-05	0.000455	CcSEcCtD
Terbinafine—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.25e-05	0.000453	CcSEcCtD
Terbinafine—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.25e-05	0.000453	CcSEcCtD
Terbinafine—Nausea—Glimepiride—type 2 diabetes mellitus	6.23e-05	0.000451	CcSEcCtD
Terbinafine—Nausea—Sitagliptin—type 2 diabetes mellitus	6.21e-05	0.00045	CcSEcCtD
Terbinafine—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.2e-05	0.000449	CcSEcCtD
Terbinafine—Asthenia—Glyburide—type 2 diabetes mellitus	6.2e-05	0.000449	CcSEcCtD
Terbinafine—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.2e-05	0.000449	CcSEcCtD
Terbinafine—Anorexia—Metformin—type 2 diabetes mellitus	6.19e-05	0.000448	CcSEcCtD
Terbinafine—Cough—Losartan—type 2 diabetes mellitus	6.17e-05	0.000447	CcSEcCtD
Terbinafine—Urticaria—Gliclazide—type 2 diabetes mellitus	6.17e-05	0.000447	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.16e-05	0.000446	CcSEcCtD
Terbinafine—Alopecia—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000446	CcSEcCtD
Terbinafine—Fatigue—Valsartan—type 2 diabetes mellitus	6.15e-05	0.000445	CcSEcCtD
Terbinafine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.000445	CcSEcCtD
Terbinafine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.000445	CcSEcCtD
Terbinafine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.13e-05	0.000444	CcSEcCtD
Terbinafine—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.13e-05	0.000444	CcSEcCtD
Terbinafine—Pruritus—Glyburide—type 2 diabetes mellitus	6.12e-05	0.000443	CcSEcCtD
Terbinafine—Mental disorder—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000442	CcSEcCtD
Terbinafine—Infection—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000441	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.09e-05	0.000441	CcSEcCtD
Terbinafine—Fatigue—Orlistat—type 2 diabetes mellitus	6.08e-05	0.00044	CcSEcCtD
Terbinafine—Erythema—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000439	CcSEcCtD
Terbinafine—Pain—Orlistat—type 2 diabetes mellitus	6.03e-05	0.000437	CcSEcCtD
Terbinafine—Myalgia—Losartan—type 2 diabetes mellitus	6.02e-05	0.000436	CcSEcCtD
Terbinafine—Arthralgia—Losartan—type 2 diabetes mellitus	6.02e-05	0.000436	CcSEcCtD
Terbinafine—Chest pain—Losartan—type 2 diabetes mellitus	6.02e-05	0.000436	CcSEcCtD
Terbinafine—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.01e-05	0.000436	CcSEcCtD
Terbinafine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.01e-05	0.000435	CcSEcCtD
Terbinafine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6e-05	0.000435	CcSEcCtD
Terbinafine—Anxiety—Losartan—type 2 diabetes mellitus	6e-05	0.000434	CcSEcCtD
Terbinafine—Rash—Bromocriptine—type 2 diabetes mellitus	5.96e-05	0.000432	CcSEcCtD
Terbinafine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.96e-05	0.000432	CcSEcCtD
Terbinafine—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.000431	CcSEcCtD
Terbinafine—Discomfort—Losartan—type 2 diabetes mellitus	5.95e-05	0.000431	CcSEcCtD
Terbinafine—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.94e-05	0.00043	CcSEcCtD
Terbinafine—Headache—Bromocriptine—type 2 diabetes mellitus	5.93e-05	0.000429	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.92e-05	0.000429	CcSEcCtD
Terbinafine—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.92e-05	0.000428	CcSEcCtD
Terbinafine—Dry mouth—Losartan—type 2 diabetes mellitus	5.89e-05	0.000426	CcSEcCtD
Terbinafine—Anorexia—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000423	CcSEcCtD
Terbinafine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.83e-05	0.000422	CcSEcCtD
Terbinafine—Paraesthesia—Metformin—type 2 diabetes mellitus	5.83e-05	0.000422	CcSEcCtD
Terbinafine—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.83e-05	0.000422	CcSEcCtD
Terbinafine—Confusional state—Losartan—type 2 diabetes mellitus	5.82e-05	0.000421	CcSEcCtD
Terbinafine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000421	CcSEcCtD
Terbinafine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.77e-05	0.000418	CcSEcCtD
Terbinafine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.76e-05	0.000417	CcSEcCtD
Terbinafine—Infection—Losartan—type 2 diabetes mellitus	5.73e-05	0.000415	CcSEcCtD
Terbinafine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.72e-05	0.000414	CcSEcCtD
Terbinafine—Dyspepsia—Metformin—type 2 diabetes mellitus	5.72e-05	0.000414	CcSEcCtD
Terbinafine—Urticaria—Valsartan—type 2 diabetes mellitus	5.67e-05	0.00041	CcSEcCtD
Terbinafine—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.66e-05	0.00041	CcSEcCtD
Terbinafine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.65e-05	0.000409	CcSEcCtD
Terbinafine—Decreased appetite—Metformin—type 2 diabetes mellitus	5.65e-05	0.000409	CcSEcCtD
Terbinafine—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.64e-05	0.000408	CcSEcCtD
Terbinafine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000407	CcSEcCtD
Terbinafine—Nausea—Bromocriptine—type 2 diabetes mellitus	5.62e-05	0.000407	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.61e-05	0.000406	CcSEcCtD
Terbinafine—Fatigue—Metformin—type 2 diabetes mellitus	5.6e-05	0.000406	CcSEcCtD
Terbinafine—Urticaria—Orlistat—type 2 diabetes mellitus	5.6e-05	0.000406	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000404	CcSEcCtD
Terbinafine—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.57e-05	0.000404	CcSEcCtD
Terbinafine—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.57e-05	0.000404	CcSEcCtD
Terbinafine—Asthenia—Gliclazide—type 2 diabetes mellitus	5.57e-05	0.000403	CcSEcCtD
Terbinafine—Angioedema—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000401	CcSEcCtD
Terbinafine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.5e-05	0.000399	CcSEcCtD
Terbinafine—CYP19A1—adipose tissue—type 2 diabetes mellitus	5.5e-05	0.0367	CbGeAlD
Terbinafine—Anorexia—Losartan—type 2 diabetes mellitus	5.5e-05	0.000398	CcSEcCtD
Terbinafine—Vomiting—Glyburide—type 2 diabetes mellitus	5.5e-05	0.000398	CcSEcCtD
Terbinafine—Pruritus—Gliclazide—type 2 diabetes mellitus	5.49e-05	0.000398	CcSEcCtD
Terbinafine—Malaise—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000396	CcSEcCtD
Terbinafine—Rash—Glyburide—type 2 diabetes mellitus	5.45e-05	0.000395	CcSEcCtD
Terbinafine—Dermatitis—Glyburide—type 2 diabetes mellitus	5.45e-05	0.000394	CcSEcCtD
Terbinafine—Vertigo—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000394	CcSEcCtD
Terbinafine—Headache—Glyburide—type 2 diabetes mellitus	5.42e-05	0.000392	CcSEcCtD
Terbinafine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.4e-05	0.000391	CcSEcCtD
Terbinafine—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.35e-05	0.000388	CcSEcCtD
Terbinafine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.33e-05	0.000386	CcSEcCtD
Terbinafine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.31e-05	0.000385	CcSEcCtD
Terbinafine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.31e-05	0.000385	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000383	CcSEcCtD
Terbinafine—Cough—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000383	CcSEcCtD
Terbinafine—Fatigue—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000383	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.26e-05	0.000381	CcSEcCtD
Terbinafine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.26e-05	0.000381	CcSEcCtD
Terbinafine—Pain—Irbesartan—type 2 diabetes mellitus	5.24e-05	0.00038	CcSEcCtD
Terbinafine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.19e-05	0.000376	CcSEcCtD
Terbinafine—Paraesthesia—Losartan—type 2 diabetes mellitus	5.18e-05	0.000375	CcSEcCtD
Terbinafine—Urticaria—Metformin—type 2 diabetes mellitus	5.16e-05	0.000374	CcSEcCtD
Terbinafine—Chest pain—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000374	CcSEcCtD
Terbinafine—Arthralgia—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000374	CcSEcCtD
Terbinafine—Myalgia—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000374	CcSEcCtD
Terbinafine—Anxiety—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000372	CcSEcCtD
Terbinafine—Nausea—Glyburide—type 2 diabetes mellitus	5.14e-05	0.000372	CcSEcCtD
Terbinafine—Abdominal pain—Metformin—type 2 diabetes mellitus	5.13e-05	0.000372	CcSEcCtD
Terbinafine—Dizziness—Gliclazide—type 2 diabetes mellitus	5.13e-05	0.000372	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000371	CcSEcCtD
Terbinafine—Asthenia—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000371	CcSEcCtD
Terbinafine—Discomfort—Ramipril—type 2 diabetes mellitus	5.1e-05	0.000369	CcSEcCtD
Terbinafine—Dyspepsia—Losartan—type 2 diabetes mellitus	5.08e-05	0.000368	CcSEcCtD
Terbinafine—Asthenia—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000366	CcSEcCtD
Terbinafine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.05e-05	0.000366	CcSEcCtD
Terbinafine—Pruritus—Valsartan—type 2 diabetes mellitus	5.05e-05	0.000365	CcSEcCtD
Terbinafine—Dry mouth—Ramipril—type 2 diabetes mellitus	5.05e-05	0.000365	CcSEcCtD
Terbinafine—Decreased appetite—Losartan—type 2 diabetes mellitus	5.01e-05	0.000363	CcSEcCtD
Terbinafine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.01e-05	0.000363	CcSEcCtD
Terbinafine—Confusional state—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000361	CcSEcCtD
Terbinafine—Pruritus—Orlistat—type 2 diabetes mellitus	4.99e-05	0.000361	CcSEcCtD
Terbinafine—Fatigue—Losartan—type 2 diabetes mellitus	4.97e-05	0.00036	CcSEcCtD
Terbinafine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000358	CcSEcCtD
Terbinafine—Vomiting—Gliclazide—type 2 diabetes mellitus	4.94e-05	0.000358	CcSEcCtD
Terbinafine—Pain—Losartan—type 2 diabetes mellitus	4.93e-05	0.000357	CcSEcCtD
Terbinafine—Rash—Gliclazide—type 2 diabetes mellitus	4.9e-05	0.000355	CcSEcCtD
Terbinafine—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.89e-05	0.000354	CcSEcCtD
Terbinafine—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.88e-05	0.000353	CcSEcCtD
Terbinafine—Urticaria—Irbesartan—type 2 diabetes mellitus	4.87e-05	0.000353	CcSEcCtD
Terbinafine—Headache—Gliclazide—type 2 diabetes mellitus	4.86e-05	0.000352	CcSEcCtD
Terbinafine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000351	CcSEcCtD
Terbinafine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000351	CcSEcCtD
Terbinafine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000351	CcSEcCtD
Terbinafine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000351	CcSEcCtD
Terbinafine—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.82e-05	0.000349	CcSEcCtD
Terbinafine—Skin disorder—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000348	CcSEcCtD
Terbinafine—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.75e-05	0.000344	CcSEcCtD
Terbinafine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.72e-05	0.000342	CcSEcCtD
Terbinafine—Dizziness—Valsartan—type 2 diabetes mellitus	4.72e-05	0.000342	CcSEcCtD
Terbinafine—Anorexia—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000341	CcSEcCtD
Terbinafine—Dizziness—Orlistat—type 2 diabetes mellitus	4.66e-05	0.000338	CcSEcCtD
Terbinafine—Asthenia—Metformin—type 2 diabetes mellitus	4.66e-05	0.000338	CcSEcCtD
Terbinafine—Nausea—Gliclazide—type 2 diabetes mellitus	4.61e-05	0.000334	CcSEcCtD
Terbinafine—Pruritus—Metformin—type 2 diabetes mellitus	4.6e-05	0.000333	CcSEcCtD
Terbinafine—Urticaria—Losartan—type 2 diabetes mellitus	4.58e-05	0.000332	CcSEcCtD
Terbinafine—Abdominal pain—Losartan—type 2 diabetes mellitus	4.56e-05	0.00033	CcSEcCtD
Terbinafine—Body temperature increased—Losartan—type 2 diabetes mellitus	4.56e-05	0.00033	CcSEcCtD
Terbinafine—Vomiting—Valsartan—type 2 diabetes mellitus	4.54e-05	0.000328	CcSEcCtD
Terbinafine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000327	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000326	CcSEcCtD
Terbinafine—Rash—Valsartan—type 2 diabetes mellitus	4.5e-05	0.000326	CcSEcCtD
Terbinafine—Dermatitis—Valsartan—type 2 diabetes mellitus	4.49e-05	0.000325	CcSEcCtD
Terbinafine—Vomiting—Orlistat—type 2 diabetes mellitus	4.48e-05	0.000325	CcSEcCtD
Terbinafine—Headache—Valsartan—type 2 diabetes mellitus	4.47e-05	0.000324	CcSEcCtD
Terbinafine—Diarrhoea—Metformin—type 2 diabetes mellitus	4.44e-05	0.000322	CcSEcCtD
Terbinafine—Rash—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000322	CcSEcCtD
Terbinafine—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000322	CcSEcCtD
Terbinafine—Dermatitis—Orlistat—type 2 diabetes mellitus	4.44e-05	0.000322	CcSEcCtD
Terbinafine—Headache—Orlistat—type 2 diabetes mellitus	4.42e-05	0.00032	CcSEcCtD
Terbinafine—Asthenia—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000319	CcSEcCtD
Terbinafine—CYP2C8—kidney—type 2 diabetes mellitus	4.37e-05	0.0291	CbGeAlD
Terbinafine—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.35e-05	0.000315	CcSEcCtD
Terbinafine—Pruritus—Irbesartan—type 2 diabetes mellitus	4.34e-05	0.000314	CcSEcCtD
Terbinafine—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000311	CcSEcCtD
Terbinafine—Dizziness—Metformin—type 2 diabetes mellitus	4.3e-05	0.000311	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000309	CcSEcCtD
Terbinafine—Fatigue—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000309	CcSEcCtD
Terbinafine—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.25e-05	0.000308	CcSEcCtD
Terbinafine—Nausea—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000307	CcSEcCtD
Terbinafine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000304	CcSEcCtD
Terbinafine—Nausea—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000303	CcSEcCtD
Terbinafine—Asthenia—Losartan—type 2 diabetes mellitus	4.14e-05	0.0003	CcSEcCtD
Terbinafine—Vomiting—Metformin—type 2 diabetes mellitus	4.13e-05	0.000299	CcSEcCtD
Terbinafine—Rash—Metformin—type 2 diabetes mellitus	4.1e-05	0.000297	CcSEcCtD
Terbinafine—Dermatitis—Metformin—type 2 diabetes mellitus	4.09e-05	0.000296	CcSEcCtD
Terbinafine—Pruritus—Losartan—type 2 diabetes mellitus	4.08e-05	0.000296	CcSEcCtD
Terbinafine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000295	CcSEcCtD
Terbinafine—Headache—Metformin—type 2 diabetes mellitus	4.07e-05	0.000295	CcSEcCtD
Terbinafine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000294	CcSEcCtD
Terbinafine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000293	CcSEcCtD
Terbinafine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	3.97e-05	0.0264	CbGeAlD
Terbinafine—Diarrhoea—Losartan—type 2 diabetes mellitus	3.95e-05	0.000286	CcSEcCtD
Terbinafine—Urticaria—Ramipril—type 2 diabetes mellitus	3.93e-05	0.000285	CcSEcCtD
Terbinafine—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000283	CcSEcCtD
Terbinafine—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000283	CcSEcCtD
Terbinafine—Vomiting—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000282	CcSEcCtD
Terbinafine—Rash—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.00028	CcSEcCtD
Terbinafine—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.00028	CcSEcCtD
Terbinafine—CYP19A1—liver—type 2 diabetes mellitus	3.86e-05	0.0257	CbGeAlD
Terbinafine—Nausea—Metformin—type 2 diabetes mellitus	3.86e-05	0.000279	CcSEcCtD
Terbinafine—Headache—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.000278	CcSEcCtD
Terbinafine—Dizziness—Losartan—type 2 diabetes mellitus	3.81e-05	0.000276	CcSEcCtD
Terbinafine—Vomiting—Losartan—type 2 diabetes mellitus	3.67e-05	0.000266	CcSEcCtD
Terbinafine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000264	CcSEcCtD
Terbinafine—Nausea—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000264	CcSEcCtD
Terbinafine—Rash—Losartan—type 2 diabetes mellitus	3.64e-05	0.000263	CcSEcCtD
Terbinafine—Dermatitis—Losartan—type 2 diabetes mellitus	3.63e-05	0.000263	CcSEcCtD
Terbinafine—PTGS1—cardiovascular system—type 2 diabetes mellitus	3.62e-05	0.0241	CbGeAlD
Terbinafine—Headache—Losartan—type 2 diabetes mellitus	3.61e-05	0.000262	CcSEcCtD
Terbinafine—Asthenia—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000257	CcSEcCtD
Terbinafine—PTGS1—kidney—type 2 diabetes mellitus	3.54e-05	0.0236	CbGeAlD
Terbinafine—Pruritus—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000253	CcSEcCtD
Terbinafine—Nausea—Losartan—type 2 diabetes mellitus	3.43e-05	0.000248	CcSEcCtD
Terbinafine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000245	CcSEcCtD
Terbinafine—Dizziness—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000237	CcSEcCtD
Terbinafine—PTGS1—adipose tissue—type 2 diabetes mellitus	3.19e-05	0.0213	CbGeAlD
Terbinafine—CYP2C19—liver—type 2 diabetes mellitus	3.17e-05	0.0211	CbGeAlD
Terbinafine—Vomiting—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000228	CcSEcCtD
Terbinafine—Rash—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000226	CcSEcCtD
Terbinafine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000226	CcSEcCtD
Terbinafine—Headache—Ramipril—type 2 diabetes mellitus	3.1e-05	0.000224	CcSEcCtD
Terbinafine—CYP3A4—kidney—type 2 diabetes mellitus	2.96e-05	0.0197	CbGeAlD
Terbinafine—Nausea—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000213	CcSEcCtD
Terbinafine—CYP2D6—kidney—type 2 diabetes mellitus	2.91e-05	0.0194	CbGeAlD
Terbinafine—CYP2C8—liver—type 2 diabetes mellitus	2.76e-05	0.0184	CbGeAlD
Terbinafine—CYP1A2—liver—type 2 diabetes mellitus	2.59e-05	0.0172	CbGeAlD
Terbinafine—CYP2C9—liver—type 2 diabetes mellitus	2.45e-05	0.0163	CbGeAlD
Terbinafine—CYP3A4—liver—type 2 diabetes mellitus	1.87e-05	0.0125	CbGeAlD
Terbinafine—CYP2D6—liver—type 2 diabetes mellitus	1.84e-05	0.0123	CbGeAlD
Terbinafine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	3.59e-06	5.06e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	3.59e-06	5.05e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	3.59e-06	5.05e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.54e-06	4.99e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.51e-06	4.95e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	3.45e-06	4.85e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	3.4e-06	4.79e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	3.4e-06	4.78e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	3.4e-06	4.78e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	3.4e-06	4.78e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.38e-06	4.76e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.38e-06	4.75e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	3.37e-06	4.74e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	3.37e-06	4.74e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	3.37e-06	4.74e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	3.36e-06	4.73e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.34e-06	4.7e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.34e-06	4.7e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.33e-06	4.69e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	3.3e-06	4.65e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.3e-06	4.65e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	3.29e-06	4.63e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	3.29e-06	4.63e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	3.28e-06	4.61e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.26e-06	4.59e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	3.25e-06	4.58e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.25e-06	4.58e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.24e-06	4.56e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.23e-06	4.55e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.23e-06	4.55e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	3.23e-06	4.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.23e-06	4.54e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	3.21e-06	4.52e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.21e-06	4.52e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.21e-06	4.52e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.21e-06	4.52e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.2e-06	4.51e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.2e-06	4.51e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.2e-06	4.51e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.19e-06	4.49e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	3.18e-06	4.48e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.13e-06	4.41e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—INS—type 2 diabetes mellitus	3.12e-06	4.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.12e-06	4.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.12e-06	4.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.12e-06	4.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.12e-06	4.39e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.11e-06	4.37e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.09e-06	4.36e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	3.09e-06	4.35e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.09e-06	4.35e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.08e-06	4.34e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	3.08e-06	4.33e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.07e-06	4.32e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.07e-06	4.32e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.04e-06	4.29e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.04e-06	4.29e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.04e-06	4.28e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3e-06	4.22e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.99e-06	4.21e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.97e-06	4.19e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.97e-06	4.18e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.95e-06	4.16e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.95e-06	4.15e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.94e-06	4.15e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.94e-06	4.15e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.92e-06	4.11e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.92e-06	4.11e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.89e-06	4.06e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.88e-06	4.05e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.88e-06	4.05e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.88e-06	4.05e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.87e-06	4.04e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	2.86e-06	4.03e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.82e-06	3.98e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.81e-06	3.96e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.8e-06	3.94e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.78e-06	3.91e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.76e-06	3.89e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.76e-06	3.89e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.76e-06	3.89e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.76e-06	3.88e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.75e-06	3.87e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.75e-06	3.87e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.74e-06	3.86e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	2.74e-06	3.85e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.74e-06	3.85e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.71e-06	3.82e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.67e-06	3.77e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.64e-06	3.72e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.63e-06	3.71e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.63e-06	3.7e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.6e-06	3.66e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.59e-06	3.65e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.56e-06	3.6e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.54e-06	3.58e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.54e-06	3.58e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.54e-06	3.57e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.54e-06	3.57e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.54e-06	3.57e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.53e-06	3.57e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.53e-06	3.56e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.52e-06	3.55e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.52e-06	3.54e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.52e-06	3.54e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.51e-06	3.54e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.5e-06	3.53e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	2.5e-06	3.52e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.49e-06	3.51e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.49e-06	3.51e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.49e-06	3.51e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.49e-06	3.51e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.49e-06	3.5e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.48e-06	3.49e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.48e-06	3.49e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.48e-06	3.49e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.47e-06	3.48e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.46e-06	3.46e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.46e-06	3.46e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.45e-06	3.45e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.42e-06	3.41e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.42e-06	3.4e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.41e-06	3.39e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.4e-06	3.38e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.39e-06	3.36e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.39e-06	3.36e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.37e-06	3.33e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.36e-06	3.32e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.36e-06	3.32e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.35e-06	3.31e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.33e-06	3.29e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.33e-06	3.28e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.31e-06	3.25e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.29e-06	3.23e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.26e-06	3.19e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.26e-06	3.18e-05	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—AKT1—type 2 diabetes mellitus	2.26e-06	3.18e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.25e-06	3.17e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.24e-06	3.16e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.23e-06	3.15e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.22e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.22e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.22e-06	3.13e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.22e-06	3.12e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.2e-06	3.09e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.18e-06	3.07e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.18e-06	3.06e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.17e-06	3.05e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.16e-06	3.04e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.15e-06	3.03e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.15e-06	3.03e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.15e-06	3.03e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.15e-06	3.03e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.14e-06	3.01e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.11e-06	2.98e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.11e-06	2.98e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.11e-06	2.97e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.11e-06	2.97e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.08e-06	2.93e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.08e-06	2.93e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.06e-06	2.9e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.05e-06	2.89e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.05e-06	2.89e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.04e-06	2.87e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.03e-06	2.86e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.02e-06	2.85e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.02e-06	2.84e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.01e-06	2.83e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.01e-06	2.83e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.99e-06	2.81e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.98e-06	2.78e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.96e-06	2.76e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.96e-06	2.76e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.94e-06	2.74e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.94e-06	2.73e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.93e-06	2.71e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.93e-06	2.71e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.93e-06	2.71e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.92e-06	2.7e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.92e-06	2.7e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.91e-06	2.7e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.91e-06	2.69e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.9e-06	2.67e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.86e-06	2.62e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.85e-06	2.6e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.84e-06	2.59e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.83e-06	2.58e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.8e-06	2.53e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.77e-06	2.49e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.77e-06	2.49e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.76e-06	2.48e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.73e-06	2.43e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.69e-06	2.38e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.67e-06	2.36e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.67e-06	2.35e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.66e-06	2.34e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.66e-06	2.34e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.65e-06	2.33e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.65e-06	2.33e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.65e-06	2.32e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.65e-06	2.32e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.64e-06	2.31e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.64e-06	2.31e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.63e-06	2.29e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.62e-06	2.28e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.62e-06	2.28e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.58e-06	2.23e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.58e-06	2.22e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.58e-06	2.22e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.54e-06	2.17e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.52e-06	2.14e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.51e-06	2.13e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.5e-06	2.12e-05	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	1.49e-06	2.1e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.48e-06	2.08e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.47e-06	2.08e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	2.04e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	2.04e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.44e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	2.03e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.44e-06	2.02e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.43e-06	2.01e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.42e-06	2e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.4e-06	1.97e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.36e-06	1.92e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.33e-06	1.88e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.33e-06	1.87e-05	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	1.85e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.29e-06	1.82e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.29e-06	1.81e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.27e-06	1.79e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.27e-06	1.78e-05	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	1.77e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.25e-06	1.76e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.23e-06	1.73e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.23e-06	1.73e-05	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.12e-06	1.58e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.1e-06	1.55e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.08e-06	1.52e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	9.92e-07	1.4e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	9.49e-07	1.34e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	9.49e-07	1.34e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	8.68e-07	1.22e-05	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	8.12e-07	1.14e-05	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	7.25e-07	1.02e-05	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.67e-07	9.39e-06	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.61e-07	9.31e-06	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.65e-07	7.96e-06	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.36e-07	6.14e-06	CbGpPWpGaD
